42 related articles for article (PubMed ID: 18711350)
1. Immunotherapeutic options for management of relapsed or refractory B-cell acute lymphoblastic leukemia: how to select newly approved agents?
Dhakal P; Kaur J; Gundabolu K; Bhatt VR
Leuk Lymphoma; 2020 Jan; 61(1):7-17. PubMed ID: 31317803
[TBL] [Abstract][Full Text] [Related]
2. Cathepsin G Is Expressed by Acute Lymphoblastic Leukemia and Is a Potential Immunotherapeutic Target.
Khan M; Carmona S; Sukhumalchandra P; Roszik J; Philips A; Perakis AA; Kerros C; Zhang M; Qiao N; John LSS; Zope M; Goldberg J; Qazilbash M; Jakher H; Clise-Dwyer K; Qiu Y; Mittendorf EA; Molldrem JJ; Kornblau SM; Alatrash G
Front Immunol; 2017; 8():1975. PubMed ID: 29422892
[TBL] [Abstract][Full Text] [Related]
3. Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells.
Kebriaei P; Singh H; Huls MH; Figliola MJ; Bassett R; Olivares S; Jena B; Dawson MJ; Kumaresan PR; Su S; Maiti S; Dai J; Moriarity B; Forget MA; Senyukov V; Orozco A; Liu T; McCarty J; Jackson RN; Moyes JS; Rondon G; Qazilbash M; Ciurea S; Alousi A; Nieto Y; Rezvani K; Marin D; Popat U; Hosing C; Shpall EJ; Kantarjian H; Keating M; Wierda W; Do KA; Largaespada DA; Lee DA; Hackett PB; Champlin RE; Cooper LJ
J Clin Invest; 2016 Sep; 126(9):3363-76. PubMed ID: 27482888
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of adults with active or progressive hematological malignancies at the time of allo-SCT: a survey from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).
Chevallier P; Labopin M; Milpied N; Bilger K; Socié G; Yakoub-Agha I; Michallet M; Bulabois CE; Maury S; Beguin Y; Bay JO; Blaise D; Maillard N; Guillerm G; Daguindeau E; Raus N; Mohty M
Bone Marrow Transplant; 2014 Mar; 49(3):361-5. PubMed ID: 24292522
[TBL] [Abstract][Full Text] [Related]
5. Comparable outcomes of partially matched related and matched related allogeneic hematopoietic cell transplantation following reduced-intensity conditioning in adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia.
Wu X; He G; Fa Y; Ma X; Wu D; Ai H; Huang X; Han Y; Xu Y; Sun A; Wu Q; Tang X; Fu Z
Int J Hematol; 2013 Oct; 98(4):456-62. PubMed ID: 23975518
[TBL] [Abstract][Full Text] [Related]
6. The role of allogeneic hematopoietic stem cell transplantation in the therapy of patients with acute lymphoblastic leukemia.
Kebriaei P; Poon LM
Curr Hematol Malig Rep; 2012 Jun; 7(2):144-52. PubMed ID: 22410763
[TBL] [Abstract][Full Text] [Related]
7. Sequential chemotherapy and myeloablative allogeneic hematopoietic stem cell transplantation for refractory acute lymphoblastic leukemia.
Arita K; Kondo T; Sugita J; Shigematsu A; Shiratori S; Wakasa K; Yasumoto A; Ibata M; Shono Y; Kikuchi M; Goto H; Takeda Y; Takahata M; Kato N; Nishio M; Ota S; Tanaka J; Imamura M
Int J Hematol; 2011 Sep; 94(3):291-295. PubMed ID: 21879292
[TBL] [Abstract][Full Text] [Related]
8. Allogeneic hematopoietic stem cell transplantation for adult acute lymphocytic leukemia.
Terwey TH; Kim TD; Arnold R
Curr Hematol Malig Rep; 2009 Jul; 4(3):139-47. PubMed ID: 20425427
[TBL] [Abstract][Full Text] [Related]
9. Reduced intensity conditioning prior to allogeneic stem cell transplantation in first complete remission is effective in patients with acute myeloid leukemia and an intermediate-risk karyotype.
Hemmati PG; Terwey TH; Massenkeil G; le Coutre P; Vuong LG; Neuburger S; Dörken B; Arnold R
Int J Hematol; 2010 Apr; 91(3):436-45. PubMed ID: 20180052
[TBL] [Abstract][Full Text] [Related]
10. Philadelphia chromosome-positive acute lymphoblastic leukemia.
Ravandi F; Kebriaei P
Hematol Oncol Clin North Am; 2009 Oct; 23(5):1043-63, vi. PubMed ID: 19825452
[TBL] [Abstract][Full Text] [Related]
11. FLAG-IDA in the treatment of refractory/relapsed adult acute lymphoblastic leukemia.
Specchia G; Pastore D; Carluccio P; Liso A; Mestice A; Rizzi R; Ciuffreda L; Pietrantuono G; Liso V
Ann Hematol; 2005 Nov; 84(12):792-5. PubMed ID: 16047203
[TBL] [Abstract][Full Text] [Related]
12. Unrelated donor allogeneic transplantation for adult acute lymphoblastic leukemia: a review.
Bachanova V; Weisdorf D
Bone Marrow Transplant; 2008 Mar; 41(5):455-64. PubMed ID: 17968329
[TBL] [Abstract][Full Text] [Related]
13. Haematopoietic SCT for children and adolescents with relapsed and refractory Hodgkin's lymphoma.
Claviez A; Sureda A; Schmitz N
Bone Marrow Transplant; 2008 Oct; 42 Suppl 2():S16-24. PubMed ID: 18978738
[TBL] [Abstract][Full Text] [Related]
14. Allogeneic SCT in refractory or relapsed adult ALL is effective without prior reinduction chemotherapy.
Terwey TH; Massenkeil G; Tamm I; Hemmati PG; Neuburger S; Martus P; Dörken B; Hoelzer D; Arnold R
Bone Marrow Transplant; 2008 Dec; 42(12):791-8. PubMed ID: 18711350
[TBL] [Abstract][Full Text] [Related]
15. Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia.
Liu QF; Fan ZP; Zhang Y; Jiang ZJ; Wang CY; Xu D; Sun J; Xiao Y; Tan H
Biol Blood Marrow Transplant; 2009 Nov; 15(11):1376-85. PubMed ID: 19822296
[TBL] [Abstract][Full Text] [Related]
16. Donor lymphocyte infusion for leukemia relapse after hematopoietic stem cell transplantation.
Yegin ZA; Ozkurt ZN; Aki SZ; Sucak GT
Transfus Apher Sci; 2010 Jun; 42(3):239-45. PubMed ID: 20385512
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
